COSMOS Pharmaceutical Corporation
CSMYF · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Market Cap | $3,651 | $524,194 | $549,810 | $466,307 |
| - Cash | $337 | $57,038 | $22,765 | $39,129 |
| + Debt | $282 | $49,957 | $28,529 | $25,675 |
| Enterprise Value | $3,596 | $517,113 | $555,574 | $452,853 |
| Revenue | $1,852 | $259,122 | $246,332 | $244,095 |
| % Growth | -99.3% | 5.2% | 0.9% | – |
| Gross Profit | $389 | $54,073 | $53,134 | $51,511 |
| % Margin | 21% | 20.9% | 21.6% | 21.1% |
| EBITDA | $122 | $15,306 | $15,921 | $14,169 |
| % Margin | 6.6% | 5.9% | 6.5% | 5.8% |
| Net Income | $56 | $8,635 | $7,915 | $6,285 |
| % Margin | 3% | 3.3% | 3.2% | 2.6% |
| EPS Diluted | 0.7 | 108.95 | 99.86 | 79.3 |
| % Growth | -99.4% | 9.1% | 25.9% | – |
| Operating Cash Flow | – | $0 | $0 | $0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | $0 | $0 | $0 |